Globe Life Inc. (NYSE:GL – Get Free Report) CEO James Matthew Darden sold 9,527 shares of Globe Life stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $144.34, for a total transaction of $1,375,127.18. Following the completion of the sale, the chief executive officer directly owned 53,860 shares of the company’s stock, valued at approximately $7,774,152.40. This trade represents a 15.03% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Globe Life Price Performance
NYSE GL opened at $145.32 on Monday. The stock has a market capitalization of $11.43 billion, a price-to-earnings ratio of 10.32 and a beta of 0.46. Globe Life Inc. has a 1-year low of $109.38 and a 1-year high of $152.71. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07. The business’s fifty day moving average price is $141.88 and its 200-day moving average price is $138.72.
Globe Life (NYSE:GL – Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.30%. The firm had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter last year, the company posted $3.14 EPS. The firm’s revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current year.
Globe Life Increases Dividend
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. Wells Fargo & Company lifted their price target on shares of Globe Life from $170.00 to $171.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 25th. Piper Sandler reiterated an “overweight” rating and set a $167.00 target price on shares of Globe Life in a research report on Friday, November 21st. Truist Financial upped their price target on Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Morgan Stanley reaffirmed an “overweight” rating and set a $176.00 price objective on shares of Globe Life in a research report on Monday, December 15th. Finally, TD Cowen reiterated a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Eight analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Globe Life currently has an average rating of “Moderate Buy” and a consensus target price of $171.33.
Read Our Latest Report on Globe Life
Key Stories Impacting Globe Life
Here are the key news stories impacting Globe Life this week:
- Positive Sentiment: Board raised the quarterly dividend to $0.33 (22.2% increase) and announced two new board members — supports income-focused investors and signals confidence in cash flow. GLOBE LIFE INC. DECLARES DIVIDEND AND ANNOUNCES APPOINTMENT OF TWO NEW BOARD MEMBERS
- Positive Sentiment: Wells Fargo published a positive price-forecast note on Globe Life, which can attract buyers and lend near-term support to the share price. Wells Fargo & Company Issues Positive Forecast for Globe Life (NYSE:GL) Stock Price
- Neutral Sentiment: Globe Life Field booked for an Eagles concert, which forced a local high school to reschedule prom — shows strong event demand and venue utilization but has minimal direct impact on insurance operations. Eagles concert at Globe Life Field moves Texas high school’s prom night date How an Eagles concert at Globe Life Field bumped a North Texas high school prom
- Neutral Sentiment: GL was included in a Zacks piece highlighting high-ROE stocks as resilient plays; such coverage may raise investor interest but is not a company-specific catalyst. Buy 5 Stocks With High ROE as Markets Dance Whimsically to the AI Tune
- Negative Sentiment: CEO James Matthew Darden sold 9,527 shares (~15% reduction in his reported ownership), a sizable insider sale that can spook some investors. SEC Form 4 – Darden sale
- Negative Sentiment: EVP Robert Edward Hensley sold 712 shares (~7.7% reduction in his holding), another insider sale that adds to selling pressure signals. SEC Form 4 – Hensley sale
- Negative Sentiment: TipRanks flagged Globe Life’s rising allocation to alternative assets as increasing volatility, capital strain and liquidity risk — a potential medium-term headwind for valuation if realized. Globe Life’s Growing Alternative Asset Bets Raise Volatility, Capital Strain and Liquidity Risk
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in GL. Vanguard Group Inc. raised its position in shares of Globe Life by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock valued at $1,411,311,000 after buying an additional 86,349 shares during the last quarter. Invesco Ltd. increased its holdings in Globe Life by 2.7% in the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock valued at $552,262,000 after acquiring an additional 102,445 shares during the last quarter. Geode Capital Management LLC lifted its stake in Globe Life by 2.9% in the 2nd quarter. Geode Capital Management LLC now owns 2,722,768 shares of the company’s stock worth $339,875,000 after purchasing an additional 76,995 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Globe Life by 2.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,135,861 shares of the company’s stock valued at $298,732,000 after purchasing an additional 59,629 shares during the last quarter. Finally, Morgan Stanley boosted its holdings in shares of Globe Life by 7.2% during the 4th quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after purchasing an additional 125,567 shares during the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Featured Stories
- Five stocks we like better than Globe Life
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
